YSB

YSB Intangible Assets

The Intangible Assets of YSB (9885.HK) as of Oct 20, 2026 is 526.50 M CNY. In the previous year, Intangible Assets was 85.31 M CNY — a change of 517.15% (higher).

Intangible Assets

526.50 MCNY

YoY

517.15%

Last updated:

Intangible Assets of YSB is 2024 526.50 M CNY. Intangible Assets of YSB was 2023 85.31 M CNY. It decreases by 517.15% higher compared to the previous year.

The YSB Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2020
62.70 M CNY
Jan 1, 2021
112.60 M CNY
Jan 1, 2022
98.90 M CNY
Jan 1, 2023
85.31 M CNY
Jan 1, 2024
526.50 M CNY
The YSB Intangible Assets history
YEARIntangible AssetsYoY
526.50 MCNY+517.15%
85.31 MCNY-13.74%
98.90 MCNY-12.17%
112.60 MCNY+79.59%
62.70 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

YSB Stock analysis

What does YSB do? YSB, Inc. generates revenue through the wholesale and retail of pharmaceuticals and healthcare products via offline and online platforms. The company operates an online platform enabling pharmaceutical distributors to sell their products, while also offering software-as-a-service (SaaS) solutions to pharmacies. Additionally, YSB sells smart unmanned pharmaceutical booths to third-party pharmacies and provides maintenance and technical support services for these booths. The firm's primary market is domestic, serving pharmacies, distributors, and primary medical institutions through its SaaS and testing services. The company's SaaS solutions target pharmacies, helping them manage operations, while the smart unmanned pharmaceutical booths are sold to third-party pharmacies for retail distribution. Medical testing services are provided directly to primary medical institutions, and the firm's online platform connects distributors with buyers. All services and products are focused on the domestic market, with no international operations mentioned in the description. YSB, Inc. makes money by selling pharmaceuticals and healthcare products through its platforms, offering SaaS to pharmacies, and providing maintenance services for smart booths. The firm's revenue streams include direct sales of products, SaaS subscriptions, booth sales, and technical support contracts. Primary customers are pharmacies, distributors, and primary medical institutions, all operating within China's domestic market. YSB is one of the most popular companies on Eulerpool.

Frequently Asked Questions about YSB stock

Intangible Assets of YSB is 526.50 M CNY in 2024.

Intangible Assets of YSB changed from 85.31 M CNY to 526.50 M CNY, representing a 517.15% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets YSB since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's YSB historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — YSB

All Key Metrics — YSB